Global Drugs For Herpes Labialis (Oral Herpes) Market Survey and Trend Research 2018

December 2017 | 105 pages | ID: G80EE9B17C9EN
99Strategy

Abstracts

SUMMARY

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (GSK, Novartis, Teva, Mylan, Apotex, Apotex, Daewoong Pharmaceutical, Livzon, Luoxin, Med shine, Bayer (Campho Phenique), Blistex, Kelun Group, Hikma, Haiwang, Carmex, Cipher etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Drugs For Herpes Labialis (Oral Herpes) Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 GSK (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Novartis (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Teva (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Mylan (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Apotex (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Apotex (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Daewoong Pharmaceutical (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Livzon (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Luoxin (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Med shine (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Bayer (Campho Phenique) (Company Overview, Sales Data etc.)
4.12 Blistex (Company Overview, Sales Data etc.)
4.13 Kelun Group (Company Overview, Sales Data etc.)
4.14 Hikma (Company Overview, Sales Data etc.)
4.15 Haiwang (Company Overview, Sales Data etc.)
4.16 Carmex (Company Overview, Sales Data etc.)
4.17 Cipher (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Type, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Type, in Volume
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2018-2023, by Type, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2018-2023, by Type, in Volume
Table GSK Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Pharmaceutical Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Daewoong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Livzon Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Livzon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luoxin Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Luoxin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Med shine Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Med shine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer (Campho Phenique) Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Bayer (Campho Phenique) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Blistex Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Blistex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kelun Group Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Kelun Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hikma Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Haiwang Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Haiwang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Carmex Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Carmex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipher Overview List
Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Cipher (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue Share, by Companies, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Volume 2012-2017, by Companies, in Volume
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue Share, by Companies in 2017, in Volume
Table Drugs For Herpes Labialis (Oral Herpes) Demand 2012-2017, by Application, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Demand 2012-2017, by Application, in Volume
Table Drugs For Herpes Labialis (Oral Herpes) Demand Forecast 2018-2023, by Application, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Demand Forecast 2018-2023, by Application, in Volume
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Region, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Region, in Volume
Table Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2018-2023, by Region, in USD Million
Table Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Drugs For Herpes Labialis (Oral Herpes) Industry Chain Structure
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2012-2017, by Type, in USD Million
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2012-2017, by Type, in Volume
Figure Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Drugs For Herpes Labialis (Oral Herpes) Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region